Nuveen’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-555,036
| Closed | -$5.06M | – | 3303 |
|
|
2025
Q2 | $5.06M | Sell |
555,036
-43,269
| -7% | -$318K | ﹤0.01% | 1876 |
|
|
2025
Q1 | $4.76M | Buy |
598,305
+455,611
| +319% | +$3.34M | ﹤0.01% | 1949 |
|
|
2024
Q4 | $775K | Hold |
142,694
| – | – | ﹤0.01% | 2816 |
|
|
2024
Q3 | $1.03M | Hold |
142,694
| – | – | ﹤0.01% | 2749 |
|
|
2024
Q2 | $1.55M | Hold |
142,694
| – | – | ﹤0.01% | 2507 |
|
|
2024
Q1 | $2.67M | Hold |
142,694
| – | – | ﹤0.01% | 2273 |
|
|
2023
Q4 | $3.09M | Buy |
142,694
+1,319
| +0.9% | +$26.1K | ﹤0.01% | 2210 |
|
|
2023
Q3 | $2.91M | Sell |
141,375
-172,074
| -55% | -$4.97M | ﹤0.01% | 2136 |
|
|
2023
Q2 | $14.7M | Buy |
313,449
+173,664
| +124% | +$8.64M | 0.01% | 1272 |
|
|
2023
Q1 | $5.87M | Sell |
139,785
-17,756
| -11% | -$763K | ﹤0.01% | 1800 |
|
|
2022
Q4 | $6.01M | Sell |
157,541
-25,502
| -14% | -$974K | ﹤0.01% | 1812 |
|
|
2022
Q3 | $7.17M | Sell |
183,043
-3,849
| -2% | -$149K | ﹤0.01% | 1686 |
|
|
2022
Q2 | $6.04M | Sell |
186,892
-39,711
| -18% | -$1.33M | ﹤0.01% | 1820 |
|
|
2022
Q1 | $7.61M | Sell |
226,603
-21,011
| -8% | -$790K | ﹤0.01% | 1814 |
|
|
2021
Q4 | $10.5M | Buy |
247,614
+12,563
| +5% | +$526K | ﹤0.01% | 1653 |
|
|
2021
Q3 | $10.4M | Buy |
235,051
+8,607
| +4% | +$395K | ﹤0.01% | 1750 |
|
|
2021
Q2 | $12.9M | Buy |
226,444
+46,976
| +26% | +$3.32M | ﹤0.01% | 1695 |
|
|
2021
Q1 | $13.4M | Sell |
179,468
-42,832
| -19% | -$3.51M | ﹤0.01% | 1611 |
|
|
2020
Q4 | $19.2M | Sell |
222,300
-31,451
| -12% | -$2.32M | 0.01% | 1292 |
|
|
2020
Q3 | $15.5M | Sell |
253,751
-26,684
| -10% | -$1.35M | 0.01% | 1219 |
|
|
2020
Q2 | $11.7M | Sell |
280,435
-78,568
| -22% | -$2.85M | ﹤0.01% | 1381 |
|
|
2020
Q1 | $10.3M | Sell |
359,003
-170,727
| -32% | -$9.89M | 0.01% | 1273 |
|
|
2019
Q4 | $38.2M | Buy |
529,730
+57,482
| +12% | +$7.07M | 0.01% | 807 |
|
|
2019
Q3 | $66.3M | Sell |
472,248
-149,177
| -24% | -$25M | 0.03% | 530 |
|
|
2019
Q2 | $114M | Buy |
+621,425
| New | +$106M | 0.04% | 390 |
|
|
2018
Q3 | – | Sell |
-5,411
| Closed | -$847K | – | 1075 |
|
|
2018
Q2 | $847K | Sell |
5,411
-5,347
| -50% | -$839K | 0.01% | 771 |
|
|
2018
Q1 | $1.73M | Buy |
10,758
+1,944
| +22% | +$330K | 0.01% | 639 |
|
|
2017
Q4 | $1.45M | Sell |
8,814
-571
| -6% | -$55.4K | 0.01% | 663 |
|
|
2017
Q3 | $585K | Buy |
9,385
+5,948
| +173% | +$467K | ﹤0.01% | 883 |
|
|
2017
Q2 | $274K | Buy |
+3,437
| New | +$248K | ﹤0.01% | 1034 |
|
|
2016
Q2 | – | Sell |
-21,620
| Closed | -$693 | – | 1396 |
|
|
2016
Q1 | $693 | Buy |
21,620
+1,327
| +7% | +$46.7K | ﹤0.01% | 1151 |
|
|
2015
Q4 | $1.18K | Sell |
20,293
-656
| -3% | -$32.5K | 0.01% | 988 |
|
|
2015
Q3 | $886 | Buy |
+20,949
| New | +$1.29M | 0.01% | 1144 |
|
Other funds holding SAGE
IA
HNB
Nuveen's SAGE Position: Q3 2025 in Review
Nuveen sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 555,036 shares — an estimated $5.06M sold.
Nuveen first reported a position in SAGE in Q3 2015 and held it in 33 quarters. The position peaked at $114M in Q2 2019. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.
- Nuveen reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
- Nuveen sold 555,036 Sage Therapeutics shares in Q3 2025, an estimated $5.06M.
- Nuveen first reported a position in Sage Therapeutics in Q3 2015 and held it in 33 quarters.
- Nuveen's Sage Therapeutics position peaked at $114M in Q2 2019.
- 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.
Based on Nuveen's 13F filing for Q3 2025, filed 12 Nov 2025.